Evidence map›Paper›PMID 41421336›Full record

ArticleMolecular cell2026

H4K16 acylations destabilize chromatin architecture and facilitate transcriptional response during metabolic perturbations.

Sandra Nitsch, Aria E Coraor, Tamas Schauer, Yiheng Wu, Jianfeng Sun, Natalie Möritz, Jonas Funke, Harsh Nagpal, Gabriella N L Chua, Federica Battistini and 10 more

Abstract read
In one paragraph

Article in Molecular cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sandra NitschInstitute of Functional Epigenetics, Helmholtz München, Munich, Germany.
Aria E CoraorPritzker School of Molecular Engineering, University of Chicago, Chicago, IL, USA; Chan Zuckerberg Biohub Chicago, Chicago, IL, USA.
Tamas SchauerInstitute of Epigenetics and Stem Cells, Helmholtz München, Munich, Germany.
Yiheng WuPritzker School of Molecular Engineering, University of Chicago, Chicago, IL, USA.
Jianfeng SunLaboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY, USA.
Natalie MöritzDepartment of Physics, TU München, Munich, Germany.
Jonas FunkeDepartment of Physics, TU München, Munich, Germany.
Harsh NagpalInstitute of Chemical Sciences and Engineering, EPFL, Lausanne, Switzerland.
Gabriella N L ChuaLaboratory of Nanoscale Biophysics and Biochemistry, The Rockefeller University, New York, NY, USA.
Federica BattistiniInstitute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain; Department of Biochemistry and Biomedicine, University of Barcelona, Barcelona, Spain.
Shannon M LauberthSimpson Querrey Institute for Epigenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Eva RichardCentro de Biología Molecular Severo Ochoa UAM-CSIC, IUBM, CIBERER, IDIPAZ, Universidad Autónoma de Madrid, Madrid, Spain.
Modesto OrozcoInstitute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, Spain; Department of Biochemistry and Biomedicine, University of Barcelona, Barcelona, Spain.
Shixin LiuLaboratory of Nanoscale Biophysics and Biochemistry, The Rockefeller University, New York, NY, USA.
Lourdes R DesviatCentro de Biología Molecular Severo Ochoa UAM-CSIC, IUBM, CIBERER, IDIPAZ, Universidad Autónoma de Madrid, Madrid, Spain.
Beat FierzInstitute of Chemical Sciences and Engineering, EPFL, Lausanne, Switzerland.
Hendrik DietzDepartment of Physics, TU München, Munich, Germany.
Robert G RoederLaboratory of Biochemistry and Molecular Biology, The Rockefeller University, New York, NY, USA.
Juan J de PabloPritzker School of Molecular Engineering, University of Chicago, Chicago, IL, USA.
Robert SchneiderInstitute of Functional Epigenetics, Helmholtz München, Munich, Germany; Faculty of Biology, LMU München, Munich, Germany; German Center for Diabetes Research, Neuherberg, Munich, Germany. Electronic address: robert.schneider@helmholtz-munich.de.

Funding

The Roles of Enhancer RNAs in the Regulation of Gene ExpressionR35GM128900 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LAUBERTH, SHANNON MARIE · 2018 to 2022
$2.0M
NIGMS NIH HHS R35 GM128900
6 · The paper itself

Abstract

Histone modifications play crucial roles in genome function. However, how chromatin integrates physiological and metabolic responses at the molecular level remains largely unknown. Acetylation of histone H4 lysine 16 (H4K16ac) is unique, as it directly regulates chromatin architecture. Here, we investigated the roles of two additional H4K16 short-chain acylations, propionylation (H4K16pr) and butyrylation (H4K16bu), in chromatin architecture and transcriptional regulation. We demonstrate distinct in vitro effects of H4K16 acylations on chromatin structure, including inter- and intra-nucleosomal interactions. Utilizing a mouse model of the metabolic disease propionic acidemia, we reveal a transcriptional response concomitant with changes in H4K16 acylations in vivo. Our work suggests the importance of simultaneous action of histone acylations for transcriptional robustness through effects on nucleosomal interactions. We propose that this mode of action distinguishes H4K16 acylations from other modifications that also differ by one carbon, such as methylations.

Indexed as

ChromatinChromatin Assembly and DisassemblyHistonesNucleosomesTranscription, GeneticAcetylationAcylationAnimalsDisease Models, AnimalGene Expression RegulationHumansMiceMice, Inbred C57BLProtein Processing, Post-TranslationalChromatinHistonesNucleosomeschromatin dynamicsH4K16 acylationsmetabolic challenge

Identifiers

PMID41421336
PMCPMC13012056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.